Get the Stockscreener App
0.00
100.00%
-0.5266
Oncternal Therapeutics Inc Stock (ONCT) Forecast
The Oncternal Therapeutics Inc (ONCT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.0867, representing a + increase from the current price of $0.00. The highest analyst price target is $6.1817, and the lowest is $3.9917.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ONCT Price Target
Average 4.008
(+ Upside)
Is Oncternal Therapeutics Inc (ONCT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 17.76 | Buy |
| STOCH(9,6) | 11.48 | Buy |
| STOCHRSI(14) | 5.7325 | Buy |
| MACD(12,26) | -0.2887 | Sell |
| ADX(14) | 25.71 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -182.44 | Sell |
Buy: 4
Sell: 3
Neutral: 0
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7948
Sell
|
0.7002
Sell
|
| MA20 |
1.0443
Sell
|
0.9422
Sell
|
| MA50 |
1.2569
Sell
|
1.5715
Sell
|
| MA100 |
2.9915
Sell
|
2.8615
Sell
|
| MA200 |
5.781
Sell
|
4.4556
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ONCT could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on ONCT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 17.76 indicates that ONCT is oversold. This indicates that ONCT price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 11.48 indicates that ONCT is oversold. This indicates that ONCT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.7325 indicates that ONCT is oversold. This suggests that ONCT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.71 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -182.44 indicates that ONCT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ONCT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Oncternal Therapeutics Inc financial reports and earnings history, Oncternal Therapeutics Inc (ONCT) stock could reach $10.48 by 2030, $1.8741 by 2040 and $3.6505 by 2050. See the projected annual prices until 2050 of the Oncternal Therapeutics Inc stock below:
- Oncternal Therapeutics Inc (ONCT) is expected to reach an average price of $1.0814 in 2035, with a high prediction of $1.0862 and a low estimate of $0.9942. This indicates an $ rise from the last recorded price of $0.00.
- Oncternal Therapeutics Inc (ONCT) stock is projected to chart a bullish course in 2040, with an average price target of $1.3611, representing an $ surge from its current level. The forecast ranges from a conservative $1.3153 to a sky-high $1.8741.
- Our analysts predict Oncternal Therapeutics Inc (ONCT) to jump by 2045, soaring from $2.1695 to an average price of $2.4596, potentially reaching $2.5296. While $2.1695 is the low estimate, the potential upside is significant.
- Oncternal Therapeutics Inc (ONCT) stock is expected to climb by 2050, reaching an average of $3.3113, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.6505 and $3.1113, respectively, highlighting the market's uncertainty.
Oncternal Therapeutics Inc Stock (ONCT) Year by Year Forecast
Oncternal Therapeutics Inc Stock (ONCT) Price Forecast for 2025
Oncternal Therapeutics Inc Stock (ONCT) is expected to reach an average price of $4.008 in 2025, with a high prediction of $6.1817 and a low estimate of $1.8343. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $4.7219 | $3.9917 | $6.1817 | + |
| February, 2025 | $4.1121 | $4.0421 | $4.6894 | + |
| March, 2025 | $3.9993 | $3.7623 | $4.7922 | + |
| April, 2025 | $3.3259 | $2.5825 | $4.5523 | + |
| May, 2025 | $3.0527 | $2.8626 | $3.7326 | + |
| June, 2025 | $2.9529 | $2.7629 | $3.3293 | + |
| July, 2025 | $3.3532 | $2.7868 | $3.9831 | + |
| August, 2025 | $2.5734 | $2.5034 | $4.1732 | + |
| September, 2025 | $3.1136 | $2.458 | $3.6935 | + |
| October, 2025 | $2.4536 | $2.3038 | $3.3936 | + |
| November, 2025 | $2.044 | $2.014 | $2.6739 | + |
| December, 2025 | $1.8943 | $1.8343 | $2.3141 | + |
Oncternal Therapeutics Inc Stock (ONCT) Price Forecast for 2026
The predicted value for Oncternal Therapeutics Inc (ONCT) in 2026 is set at an average of $6.3749. Estimates vary from a peak of $10.91 to a trough of $1.8443, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.0145 | $1.8443 | $6.6244 | + |
| February, 2026 | $4.7347 | $2.7546 | $7.5346 | + |
| March, 2026 | $5.8249 | $4.6447 | $6.2849 | + |
| April, 2026 | $7.8251 | $5.405 | $8.9951 | + |
| May, 2026 | $9.3453 | $4.9352 | $9.7053 | + |
| June, 2026 | $8.6055 | $7.4254 | $10.91 | + |
| July, 2026 | $5.3258 | $5.1658 | $8.0256 | + |
| August, 2026 | $5.766 | $5.2359 | $6.5857 | + |
| September, 2026 | $4.8262 | $4.5462 | $5.916 | + |
| October, 2026 | $4.5564 | $3.9764 | $4.8963 | + |
| November, 2026 | $4.8666 | $3.6665 | $4.8766 | + |
| December, 2026 | $4.5269 | $4.2368 | $4.9769 | + |
Oncternal Therapeutics Inc Stock (ONCT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Oncternal Therapeutics Inc (ONCT) is $2.9381, with a high forecast of $4.8372 and a low forecast of $1.0389. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.0371 | $3.9493 | $4.5869 | + |
| February, 2027 | $3.4773 | $3.4773 | $4.8372 | + |
| March, 2027 | $3.0575 | $2.7175 | $3.5373 | + |
| April, 2027 | $2.3777 | $2.2977 | $3.0676 | + |
| May, 2027 | $2.3079 | $1.9678 | $2.5079 | + |
| June, 2027 | $1.9782 | $1.9582 | $2.548 | + |
| July, 2027 | $1.7384 | $1.6984 | $2.1082 | + |
| August, 2027 | $1.3435 | $1.3099 | $1.8185 | + |
| September, 2027 | $1.8888 | $1.0389 | $1.9588 | + |
| October, 2027 | $1.469 | $1.419 | $2.2189 | + |
| November, 2027 | $1.4892 | $1.3442 | $1.639 | + |
| December, 2027 | $1.5094 | $1.3394 | $1.6193 | + |
Oncternal Therapeutics Inc Stock (ONCT) Price Forecast for 2028
In 2028, Oncternal Therapeutics Inc (ONCT) is projected to reach an average price of $1.181, with a high projection of $1.7495 and a low estimate of $0.6124. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.4496 | $1.4296 | $1.7495 | + |
| February, 2028 | $1.2414 | $1.1201 | $1.4797 | + |
| March, 2028 | $1.4001 | $1.26 | $1.4799 | + |
| April, 2028 | $1.3203 | $1.2102 | $1.4301 | + |
| May, 2028 | $1.3155 | $1.1805 | $1.5304 | + |
| June, 2028 | $1.5207 | $1.2566 | $1.6807 | + |
| July, 2028 | $1.4109 | $1.3809 | $1.5508 | + |
| August, 2028 | $1.1011 | $1.0612 | $1.441 | + |
| September, 2028 | $0.6266 | $0.6214 | $1.2333 | + |
| October, 2028 | $0.6816 | $0.6124 | $0.7211 | + |
| November, 2028 | $0.6578 | $0.6318 | $0.6917 | + |
| December, 2028 | $0.697 | $0.646 | $0.7718 | + |
Oncternal Therapeutics Inc Stock (ONCT) Price Forecast for 2029
The 2029 price forecast for Oncternal Therapeutics Inc Stock (ONCT) is $5.80 on average, with a high prediction of $10.97 and a low estimate of $0.6329. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.7226 | $0.6926 | $0.8641 | + |
| February, 2029 | $0.6825 | $0.6445 | $0.7462 | + |
| March, 2029 | $0.7027 | $0.6401 | $0.7027 | + |
| April, 2029 | $0.6479 | $0.6329 | $0.713 | + |
| May, 2029 | $0.6431 | $0.6409 | $0.7331 | + |
| June, 2029 | $0.6953 | $0.6432 | $0.7448 | + |
| July, 2029 | $0.8897 | $0.6646 | $1.0105 | + |
| August, 2029 | $10.12 | $0.6946 | $10.47 | + |
| September, 2029 | $9.394 | $8.7239 | $10.75 | + |
| October, 2029 | $8.5742 | $7.8361 | $10.97 | + |
| November, 2029 | $9.2144 | $8.3543 | $10.21 | + |
| December, 2029 | $8.59 | $8.24 | $9.4345 | + |
Oncternal Therapeutics Inc Stock (ONCT) Price Forecast for 2030
Oncternal Therapeutics Inc Stock (ONCT) is expected to reach an average price of $6.7027 in 2030, with a high forecast of $10.48 and a low forecast of $2.925. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.5405 | $5.5405 | $10.48 | + |
| February, 2030 | $6.3209 | $6.1109 | $8.9106 | + |
| March, 2030 | $4.8413 | $4.1113 | $6.301 | + |
| April, 2030 | $6.2293 | $4.4714 | $6.6216 | + |
| May, 2030 | $5.5322 | $5.2568 | $6.762 | + |
| June, 2030 | $6.1526 | $4.9274 | $6.3875 | + |
| July, 2030 | $6.6331 | $5.9327 | $6.973 | + |
| August, 2030 | $4.9235 | $4.3335 | $6.8582 | + |
| September, 2030 | $4.8189 | $4.5836 | $5.2841 | + |
| October, 2030 | $4.6544 | $4.3842 | $5.024 | + |
| November, 2030 | $3.9248 | $3.7348 | $5.1345 | + |
| December, 2030 | $3.5952 | $2.925 | $4.4949 | + |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):